DRC Bundibugyo Ebola Outbreak Deepens as Cross-Border Cases Emerge
The Bundibugyo virus disease outbreak in the Democratic Republic of the Congo has moved beyond a purely local emergency. With Alimbongo health zone in North Kivu newly affected and Kenya confirming an imported case linked to travel from the DRC, the epidemic is now testing public health systems across borders as well as within the country’s eastern provinces.
As of 6 October 2026, the DRC has recorded 8728 confirmed cases and 4205 confirmed deaths, a crude case fatality ratio of 48.2%. The scale alone is sobering. More revealing is the pattern of transmission: 64 health zones across seven provinces now report confirmed cases, and 48 of those zones have reported at least one new case during the preceding 21 days. The outbreak is not burning evenly. Some areas are slowing, while others continue to generate fresh infections and deaths.
A one-sentence reality cuts through the numbers: the outbreak is still moving.
Deaths Continue to Reflect Delayed Detection and Community Transmission
Over the three completed epidemiological weeks before the latest report, weekly cases increased from 475 to 487, while weekly deaths remained essentially unchanged at 224 versus 222. That steady death toll, despite signs of slowing in some districts, points to ongoing gaps in early case identification and timely treatment. Since the last update, 264 of 372 reported deaths occurred in communities and 108 in treatment centres. Community deaths are more than a statistic; they are a marker of missed opportunities for isolation, supportive care, and infection prevention before the virus has a chance to spread further.
The latest 24-hour period brought 62 confirmed cases, with Ituri accounting for 33 and North Kivu for 30. No new cases were reported in Bas-Uélé, South Kivu, or Sud-Ubangi during that interval. Across the preceding seven days, the average rose to 72 new cases per day. Ituri remains the epicentre, with 6480 cumulative confirmed cases and 2989 deaths. North Kivu follows with 1755 cases and 1013 deaths, and it continues to post the highest provincial crude CFR at 57.7%.
The burden is also concentrated within specific health zones. Beni and Katwa in North Kivu, together with Rwampara, Bunia, and Mandima in Ituri, have carried much of the load. In practical terms, that means response teams are dealing with a moving patchwork of high-transmission pockets rather than one uniformly contained cluster. This kind of spatial heterogeneity is typical of Ebola outbreaks once they spread through dense and mobile populations, especially where care-seeking is delayed and surveillance coverage remains incomplete.
Contact Tracing Coverage Is Improving, but Not Enough to Close the Gap
Contact follow-up remains a major operational strain. Coverage briefly rose above the 85% target on 16 September at 87.6%, then fell to 74.7% by 25 September. It later improved to 82.0% on 27 September and stood at 80.4% in the latest reporting period, with 23 741 of 29 535 contacts reached as of 4 October. Those fluctuations matter because Ebola control depends on finding exposed people every day across a 21-day incubation period. When contact tracing slips, chains of transmission can continue undetected long enough to seed new health zones or new provinces.
Alimbongo in North Kivu is the newest affected health zone, with four confirmed cases and two deaths. Expansion into a new zone after months of activity shows that the outbreak still has fuel, even where some local transmission appears to be easing. The geographic footprint is large, and the pressure on frontline teams remains severe.
Kenya’s Imported Case Shows How Easily Ebola Can Travel With Care-Seeking
On 6 October, Kenya reported its first laboratory-confirmed imported case of BVD. The patient was an adult who lived in the DRC, became ill about a month earlier, and received care in several hospitals while in the DRC before traveling by road to Kampala and then by air to Nairobi on 3 October. A relative transported him directly to Nairobi Hospital on arrival, where he was isolated. A sample collected on 5 October was positive for Bundibugyo virus at both the National Virology Reference Laboratory and the Kenya Medical Research Institute Laboratory the same day. He received supportive care but died afterward.
The sequence matters clinically. Ebola’s incubation period is typically two to 21 days, and the disease is not infectious until symptoms begin. A one-month interval from symptom onset to death is longer than the usual course for Ebola disease, which raises the likelihood that infection was acquired later, possibly in a health facility or community setting while the patient was seeking care for another illness. In settings where malaria, febrile syndromes, and Ebola symptoms overlap early, diagnosis can be delayed until the patient is already severely ill and has crossed multiple care sites.
A safe and dignified burial was conducted, and public health response measures were started immediately. Contact tracing is ongoing, including for the international flight.
Health-Care Exposure Remains a Core Driver of Risk
A second cross-border event involved a healthcare worker who tested positive by PCR in the DRC and was medically evacuated to the Netherlands on 1 October after working on the outbreak response. The patient is being treated in the Netherlands under strict medical and infection-prevention procedures. This will not be counted as a local case in the Netherlands, but it reinforces a central feature of Ebola control: health workers are exposed when infection prevention and control fail or when high-risk care is delivered under intense outbreak pressure.
Bundibugyo virus disease is a severe Ebola disease caused by the Bundibugyo virus, a zoonotic Orthoebolavirus. Fruit bats are suspected to be the natural reservoir. Human infection can begin through contact with infected wildlife and then spread person to person through blood, secretions, organs, bodily fluids, or contaminated surfaces. Transmission is amplified in health-care settings when infection prevention and control measures are weak, and during unsafe burials involving direct contact with deceased individuals.
The disease starts with non-specific symptoms such as fever, fatigue, muscle pain, headache, and sore throat. Those early signs can resemble malaria or other endemic febrile illnesses, which complicates clinical recognition. Later progression to gastrointestinal illness, organ dysfunction, and sometimes haemorrhagic manifestations makes late-stage disease much harder to reverse. No approved vaccines or specific treatments currently exist for BVD, so outbreak control depends on rapid case identification, laboratory testing, isolation, supportive care, contact tracing, safe burials, and community engagement.
Regional Risk Stays Elevated Even as Global Risk Remains Low
WHO’s latest risk assessment places the threat in the DRC as very high and the risk for countries sharing land borders with the DRC as high, while the rest of the African Region and the global level remain low. Those ratings reflect the combination of sustained transmission, repeated cross-border movement, and the difficulty of maintaining perfect surveillance across large and mobile populations. WHO is also conducting a detailed rapid risk assessment for Kenya.
WHO advises against travel or trade restrictions with affected countries, while urging coordinated outbreak control, cross-border collaboration, and sustained surveillance and preparedness. Rapid recognition of cases, testing, and optimized supportive care can reduce mortality and improve community trust in health services during an outbreak that has already become the largest Ebola disease outbreak ever recorded in the DRC, regardless of virus species. The unanswered operational challenge is whether response coverage can keep pace with transmission in the health zones that remain active while the epidemic continues to export cases across borders.